This May, Blue Faery: The Adrienne Wilson Liver Cancer Association proudly continues its award-winning Love Your Liver campaign, now in its fifth consecutive year. This life-saving, culturally tailored initiative raises awareness about liver cancer risk factors impacting Asian American and Pacific Islander (AAPI) communities.

Asian Americans are twice as likely as White Americans to be infected with chronic hepatitis B, the leading cause of liver cancer in this population. Foreign-born Asian Americans face even higher risks. The lack of early symptoms, coupled with language, stigma, and access barriers, makes liver cancer one of the most significant health disparities in this community.

In this micro learning developed by experts Prof. Aiwu Ruth He and Prof. Beau Toskich, you’ll learn about the expanding role of immunotherapy (IO) in hepatocellular carcinoma (HCC) and treatment strategies of combining it with locoregional therapy (LRT) for patients with intermediate HCC.

Discover insights from the Phase 3 LEAP-012 study evaluating lenvatinib + pembrolizumab + TACE versus double placebo + TACE for patients with intermediate HCC.

In this short expert video, Prof. Arndt Vogel covers the key findings from the publication and places the results into clinical context.

Blue Faery is proud to announce the continuation of its annual Love Your Liver campaign during Black History Month, marking the fourth consecutive year of this impactful and award-winning initiative. This campaign aims to raise awareness about liver disease and cancer within Black/African American communities, who are 1.5 times more likely to develop liver cancer compared to the general population. 

Community members can understand their specific liver cancer risks through the Love Your Liver program and learn about proactive management strategies. Conditions such as type 2 diabetes and hepatitis C can lead to liver cancer, making education and early detection crucial for improving survival rates.

In this final episode of the four-part series on hepatocellular carcinoma (HCC), hosted by the Oncology Brothers, Drs Rohit and Rahul Gosain, the discussion focuses on the evolving role of immunotherapy (IO) in intermediate HCC.

The episode explores multimodal approaches that combine IO and IO-based therapies with loco-regional treatments and highlights the essential role of a multidisciplinary care team.

In the third of this 4-part podcast series on hepatocellular carcinoma (HCC), the Oncology Brothers, Dr Rahul and Dr Rohit Gosain, are joined by hepatologist Dr Maria Reig and interventional radiologist Dr Emil Cohen to explore treatment strategies for patients with intermediate-stage HCC.

In the second episode of a 4-part podcast series on HCC, the Oncology Brothers, Drs Rahul and Rohit Gosain, host a podcast discussion between Dr Lorenza Rimassa and Prof. Arndt Vogel on 2nd line treatment selection in advanced HCC and when to switch. 

In the first of this 4-part podcast series, Dr Rachna Shroff and the Oncology Brothers, Drs Rohit and Rahul Gosain, explore the use of immunotherapy (IO) in unresectable hepatocellular carcinoma (uHCC).

Love Your Liver helps raise awareness about liver cancer risk factors in the Hispanic community, as they are 2.5 times as likely to develop the disease compared with White Americans. Due to the high prevalence of fatty liver disease in the community, liver cancer continues to be one of the most significant health issues that Hispanic Americans face. Besides the stigma of liver cancer and fatty liver disease, Hispanic Americans also face language and cultural barriers and lack culturally appropriate educational programs. Love Your Liver delivers culturally relevant education about liver cancer risk factors, liver cancer surveillance, and treatments while offering hope.

Love Your Liver helps raise awareness about liver cancer risk factors in the Hispanic community, as they are 2.5 times as likely to develop the disease compared with White Americans. Due to the high prevalence of fatty liver disease in the community, liver cancer continues to be one of the most significant health issues that Hispanic Americans face. Besides the stigma of liver cancer and fatty liver disease, Hispanic Americans also face language and cultural barriers and lack culturally appropriate educational programs. Love Your Liver delivers culturally relevant education about liver cancer risk factors, liver cancer surveillance, and treatments while offering hope.

Black/African Americans are 50% more likely to get liver cancer than the general population, and incidence rates are climbing. The Love Your Liver campaign provides community members with convenient opportunities to learn more about their unique liver cancer risks and how to actively manage them. Type 2 diabetes and hepatitis C can both lead to liver cancer, so those in the Black/African American community who currently have or previously had one or both of those diseases are at higher risk for liver cancer. Both type 2 diabetes and hepatitis C are preventable and treatable, so education and early detection are vital to improving survival rates.

Love Your Liver Live, a Black History Month Community Event series, kicks off on February 22, 2024, at 7 p.m. ET with a live, virtual education workshop featuring Miriam Atkins, MD, a medical oncologist with multispecialty clinics in Georgia and South Carolina. The second live, virtual educational workshop will be on February 29, 2024, at 8 p.m. ET and features Gia Landry, MD, a hepatologist with Ochsner in Baton Rouge. These free virtual workshops allow community members to learn about relevant liver cancer risks and how to manage them from a trusted local physician.

You might not think about your liver health very often. If everything’s in good working order, you might not think you have to. But, according to the American Liver Foundation, liver disease affects more than 100 million Americans. The foundation cautions that when it’s left untreated, liver disease can lead to liver failure, cancer and can even be fatal—in 2020, it was the 12th leading cause of death in the US. With numbers like those, and a personal history with liver disease, former Yankees star Bernie Williams is stepping up to bat to help spread awareness about the importance of supporting your liver health.

He recently helped launch One Liver to Love in partnership with Eisai as well as Global Liver Institute (GLI) and Blue Faery, which are both patient advocacy organizations that provide education and resources to people living with liver cancer. The initiative hopes to offer support to families like Williams’ who are impacted by liver disease.

Meet our campaign spokesperson Cuban-born American singer Jon Secada. With multiple Grammy Awards and 15+ million records sold, Jon is one of the best-selling Latin music artists of all time.

"Liver disease is personal to me. It has impacted my mom, my uncle and my grandfather, and I've seen first-hand the difficulties and feelings that come with it," said Williams.